Lexicon Shares Jump 34% on Positive Diabetes Drug Data
Shares of Lexicon Pharmaceuticals Inc. (LXRX) are trading up 34.11% at $2.03 per share during Thursday’s mid – morning trading session. The biopharmaceutical company said a study of its LX4211, a new oral diabetes drug, for treating type 2 diabetes showed “positive” results. “The significant elevations of GLP-1 levels observed in the study are particularly [...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here